======= TBX6 ======= == Gene Information == * **Official Symbol**: TBX6 * **Official Name**: T-box transcription factor 6 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6911|6911]] * **UniProt**: [[https://www.uniprot.org/uniprot/O95947|O95947]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TBX6&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TBX6|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602427|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. Knockout studies in mice indicate that this gene is important for specification of paraxial mesoderm structures. [provided by RefSeq, Aug 2008]. * **UniProt Summary**: T-box transcription factor that plays an essential role in the determination of the fate of axial stem cells: neural vs mesodermal. Acts in part by down-regulating, a specific enhancer (N1) of SOX2, to inhibit neural development. Seems to play also an essential role in left/right axis determination and acts through effects on Notch signaling around the node as well as through an effect on the morphology and motility of the nodal cilia (By similarity). {ECO:0000250}. |T-box| |negative regulation of neuron maturation| |negative regulation of cell maturation| |regulation of neuron maturation| |somite rostral/caudal axis specification| |signal transduction involved in regulation of gene expression| |regulation of cell maturation| |embryonic axis specification| |anterior/posterior axis specification| |RNA polymerase II activating transcription factor binding| |heart looping| |embryonic pattern specification| |RNA polymerase II transcription factor binding| |somitogenesis| |determination of heart left/right asymmetry| |embryonic heart tube morphogenesis| |mesoderm formation| |mesoderm morphogenesis| |embryonic heart tube development| |somite development| |axis specification| |cell fate specification| |segmentation| |RNA polymerase II distal enhancer sequence-specific DNA binding| |formation of primary germ layer| |determination of left/right symmetry| |determination of bilateral symmetry| |mesoderm development| |specification of symmetry| |negative regulation of neuron projection development| |gastrulation| |negative regulation of DNA-binding transcription factor activity| |cardiac chamber development| |negative regulation of cell projection organization| |anterior/posterior pattern specification| |negative regulation of neuron differentiation| |nuclear chromatin| |cell fate commitment| |heart morphogenesis| |embryonic organ morphogenesis| |negative regulation of neurogenesis| |epithelial tube morphogenesis| |negative regulation of nervous system development| |RNA polymerase II regulatory region sequence-specific DNA binding| |regionalization| |negative regulation of cell development| |regulation of DNA-binding transcription factor activity| |morphogenesis of an epithelium| |embryonic organ development| |pattern specification process| |DNA-binding transcription activator activity, RNA polymerase II-specific| |regulation of neuron projection development| |heart development| |tissue morphogenesis| |embryonic morphogenesis| |chordate embryonic development| |embryo development ending in birth or egg hatching| |tube morphogenesis| |regulation of neuron differentiation| |regulation of plasma membrane bounded cell projection organization| |negative regulation of cellular component organization| |regulation of cell projection organization| |negative regulation of cell differentiation| |regulation of neurogenesis| |tube development| |negative regulation of transcription by RNA polymerase II| |circulatory system development| |anatomical structure formation involved in morphogenesis| |positive regulation of cell population proliferation| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |animal organ morphogenesis| |embryo development| |central nervous system development| |epithelium development| |negative regulation of molecular function| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |generation of neurons| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of cell population proliferation| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |tissue development| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9465 * **Expression level (log2 read counts)**: 2.27 {{:chemogenomics:nalm6 dist.png?nolink |}}